BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35277194)

  • 1. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
    Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
    Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [G6PC knockdown blocks AKT/mTOR pathway to inhibit proliferation, invasion and migration of cervical cancer HeLa cells].
    Deng C; Zhu K; Liu T; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jun; 37(6):520-526. PubMed ID: 34060447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
    Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X
    Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling.
    Li H; Zhang W; Yan M; Qiu J; Chen J; Sun X; Chen X; Song L; Zhang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):33. PubMed ID: 30678687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.
    Wang J; Ou J; Guo Y; Dai T; Li X; Liu J; Xia M; Liu L; He M
    Br J Cancer; 2014 Jul; 111(1):112-24. PubMed ID: 24874481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
    BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways.
    Zhang D; Sun G; Zhang H; Tian J; Li Y
    Biomed Pharmacother; 2017 Jan; 85():511-516. PubMed ID: 27899255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R; Wang H; Yang B
    Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
    Yang X; Sun F; Gao Y; Li M; Liu M; Wei Y; Jie Q; Wang Y; Mei J; Mei J; Ma L; Shi Y; Chen M; Li Y; Li Q; Liu M; Ma Y
    J Exp Clin Cancer Res; 2023 Oct; 42(1):268. PubMed ID: 37845756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.
    Zeng J; He SL; Li LJ; Wang C
    Mol Med; 2021 Oct; 27(1):130. PubMed ID: 34666670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.